Italy has introduced a revolutionary technology known as MrgFUS, which utilizes focused ultrasound guided by magnetic resonance imaging to treat patients suffering from Parkinson's disease and brain tumors. This method offers a significant advantage by allowing treatment without the need for anesthesia, incisions, or traditional surgery, thus minimizing pain and recovery time for patients. The technology, which can lead to rapid elimination of uncontrollable tremors, marks a significant advancement in medical care for neurological conditions.

In December, the latest generation system 'Exablate Prime' was installed at the Besta Institute in Milan, funded by the Lombardy Region. This state-of-the-art system has been designed to reduce the procedural time by approximately one third, enhancing the efficiency of treatments that have been available since 2019. The Besta Institute is notable for being one of the first centers in Europe to adopt this innovative technology, utilizing intraoperative MRI alongside MrgFUS to open new avenues for research and treatment of various brain-related ailments such as Alzheimer's disease.

The accessibility of this high-tech treatment allows for improved patient pathways, providing hope for individuals affected by debilitating conditions like Parkinson's and brain tumors. As more facilities may adopt this promising technique, it holds the potential to transform therapeutic approaches in neurology and oncology, paving the way for further advancements in non-invasive medical treatments.